1. Home
  2. LBTYK vs HALO Comparison

LBTYK vs HALO Comparison

Compare LBTYK & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBTYK
  • HALO
  • Stock Information
  • Founded
  • LBTYK 2004
  • HALO 1998
  • Country
  • LBTYK Bermuda
  • HALO United States
  • Employees
  • LBTYK N/A
  • HALO N/A
  • Industry
  • LBTYK Cable & Other Pay Television Services
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LBTYK Telecommunications
  • HALO Health Care
  • Exchange
  • LBTYK Nasdaq
  • HALO Nasdaq
  • Market Cap
  • LBTYK 7.9B
  • HALO 6.4B
  • IPO Year
  • LBTYK N/A
  • HALO N/A
  • Fundamental
  • Price
  • LBTYK $12.45
  • HALO $45.65
  • Analyst Decision
  • LBTYK
  • HALO Buy
  • Analyst Count
  • LBTYK 0
  • HALO 9
  • Target Price
  • LBTYK N/A
  • HALO $61.11
  • AVG Volume (30 Days)
  • LBTYK 1.6M
  • HALO 1.7M
  • Earning Date
  • LBTYK 01-01-0001
  • HALO 10-31-2024
  • Dividend Yield
  • LBTYK N/A
  • HALO N/A
  • EPS Growth
  • LBTYK N/A
  • HALO 61.71
  • EPS
  • LBTYK N/A
  • HALO 3.02
  • Revenue
  • LBTYK $7,674,500,000.00
  • HALO $947,355,000.00
  • Revenue This Year
  • LBTYK $0.23
  • HALO $23.36
  • Revenue Next Year
  • LBTYK $0.93
  • HALO $15.15
  • P/E Ratio
  • LBTYK N/A
  • HALO $15.10
  • Revenue Growth
  • LBTYK 3.53
  • HALO 21.35
  • 52 Week Low
  • LBTYK $11.25
  • HALO $33.15
  • 52 Week High
  • LBTYK $22.14
  • HALO $65.53
  • Technical
  • Relative Strength Index (RSI)
  • LBTYK 16.40
  • HALO 30.20
  • Support Level
  • LBTYK $11.25
  • HALO $50.01
  • Resistance Level
  • LBTYK $12.85
  • HALO $62.13
  • Average True Range (ATR)
  • LBTYK 0.62
  • HALO 2.60
  • MACD
  • LBTYK -1.00
  • HALO -0.50
  • Stochastic Oscillator
  • LBTYK 11.54
  • HALO 0.15

About LBTYK Liberty Global Ltd. Class C

Liberty Global is a holding company with interests in several telecom companies in the U.K., Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: